The rapid integration of artificial intelligence (AI) into healthcare settings across the United States presents significant opportunities and profound challenges. Legislative approaches to regulating AI in healthcare are diverse, reflecting the complex needs of balancing patient safety with
ICU Medical, a prominent medical device company based in California, is currently navigating significant regulatory challenges related to their infusion pumps. These challenges have emerged following an FDA warning, which highlighted the company's failure to adhere to essential regulatory
The rapid advancements in artificial intelligence (AI) have begun to significantly impact various domains, including virology. A recent study has shed light on the remarkable capabilities of AI models like ChatGPT and Claude, which have proven to surpass PhD-level virologists in solving complex lab
The field of acute coronary syndrome (ACS) care has witnessed significant advancements, driven by an evolving understanding of patient management practices and continuous clinical research efforts. These innovations encompass various aspects of treatment, from rethinking established protocols like
In a groundbreaking initiative, Burjeel Holdings is joining forces with Caring Cross to establish advanced biomanufacturing facilities dedicated to chimeric antigen receptor (CAR)-T cell therapies in the United Arab Emirates (UAE). This collaboration aims to revolutionize the production and
Roche's Columvi, a bispecific antibody known as glofitamab, has been approved by the European Commission (EC) for use in combination with gemcitabine and oxaliplatin (GemOx) to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in adults who are not candidates for autologous
